Lantern Pharma Inc. (LTRN) DCF Valuation

Lantern Pharma Inc. (LTRN) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Lantern Pharma Inc. (LTRN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (LTRN) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Lantern Pharma Inc., you can adjust forecasts and view the results instantly.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -2.4 -5.9 -12.3 -14.4 -15.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .1 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -2.4 -5.9 -12.4 -14.6 -16.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 1.2 19.2 70.7 55.2 41.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 -.2 -.6 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 .4 .7 .9 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.4 -5.9 -12.3 -14.4 -16.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.0 -6.0 -11.8 -13.6 -17.3 .0 .0 .0 .0 .0
WACC, % 11.8 11.8 11.8 11.8 11.8 11.8 11.8 11.8 11.8 11.8
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -22
Equity Value 22
Diluted Shares Outstanding, MM 11
Equity Value Per Share 2.00

What You Will Get

  • Real Lantern Pharma Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Lantern Pharma Inc. (LTRN).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Lantern Pharma Inc. (LTRN).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Lantern Pharma Inc. (LTRN)’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Lantern Pharma Inc. (LTRN).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Lantern Pharma Inc. (LTRN).

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future forecasts specific to Lantern Pharma Inc. (LTRN).
  • Adjustable Forecast Parameters: Modify highlighted fields for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatically refresh DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
  • Designed for All Skill Levels: An easy-to-navigate layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Lantern Pharma Inc. (LTRN) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Lantern Pharma Inc.'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Lantern Pharma Inc. (LTRN)?

  • Accurate Data: Utilize real Lantern Pharma financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the effort of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple interface and guided instructions make it accessible for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Lantern Pharma Inc. (LTRN) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Lantern Pharma Inc. (LTRN).
  • Consultants: Deliver professional valuation insights on Lantern Pharma Inc. (LTRN) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Lantern Pharma Inc. (LTRN) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Lantern Pharma Inc. (LTRN).

What the Template Contains

  • Historical Data: Includes Lantern Pharma Inc.'s (LTRN) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Lantern Pharma Inc.'s (LTRN) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Lantern Pharma Inc.'s (LTRN) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.